An Open Trial to Assess the Tolerability of AVANZ Olive Immunotherapy

NCT01674595 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis Due to Olea Europaea Pollen

Interventions

BIOLOGICAL: AVANZ olea

Sponsor

ALK-Abelló A/S